Clinical Trials
8 trialsNCT03933826 2026-05-12
CISTO
University of Washington
Active not recruiting
NCT05597085 2025-02-04
A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment
Pfizer
Completed
NCT05986682 2025-02-03
Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and/or Refractory Multiple Myeloma
Duke University
Completed
NCT04089488 2023-09-01
Incidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin America
AIDS Malignancy Consortium
Completed
NCT02139592 2020-07-13
Brentuximab Vedotin (Recombinant) for IV Infusion - Special Drug Use Surveillance (All-case Surveillance) "Relapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell Lymphoma"
Takeda
Completed
NCT01326728 2018-06-06
Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
National Institutes of Health Clinical Center (CC)
Terminated
NCT02486952 2016-02-22
MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma
Hoffmann-La Roche
Completed
NCT01192282 2013-01-24
Typing of Human Papilloma Virus (HPV) From Female Genital Warts
University of Cape Town
Completed